Pages that link to "Q34657645"
Jump to navigation
Jump to search
The following pages link to Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair (Q34657645):
Displaying 50 items.
- Gene delivery strategies to promote spinal cord repair (Q26825131) (← links)
- Neurotrophins and the immune system (Q28191216) (← links)
- Neurobiology of rehabilitation (Q30987500) (← links)
- Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury (Q33421738) (← links)
- Chondroitin sulfate proteoglycans regulate the growth, differentiation and migration of multipotent neural precursor cells through the integrin signaling pathway (Q33511675) (← links)
- Voiding reflex in chronic spinal cord injured cats induced by stimulating and blocking pudendal nerves (Q33649596) (← links)
- In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair. (Q33750781) (← links)
- Basic advances and new avenues in therapy of spinal cord injury (Q34181854) (← links)
- Survival and neural differentiation of adult neural stem cells transplanted into the mature inner ear. (Q34367374) (← links)
- Topography, cell response, and nerve regeneration (Q34470324) (← links)
- Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration. (Q34482943) (← links)
- Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. (Q34713207) (← links)
- Paralysis recovery in humans and model systems (Q35029592) (← links)
- Olfactory ensheathing glia transplantation: a therapy to promote repair in the mammalian central nervous system (Q35078705) (← links)
- Engineering of the Extracellular Matrix: Working toward Neural Stem Cell Programming and Neurorestoration— Concept and Progress Report (Q35109187) (← links)
- Therapeutic Gene Transfer to the Nervous System Using Viral Vectors (Q35112002) (← links)
- Stem cells in the treatment of amyotrophic lateral sclerosis (ALS). (Q35113106) (← links)
- Viral vectors for gene delivery to the nervous system (Q35120134) (← links)
- Ethical issues in molecular medicine of relevance to surgeons. (Q35537370) (← links)
- Use of gene therapy in central nervous system repair (Q35599603) (← links)
- Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. (Q35618384) (← links)
- Enhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variant (Q35635046) (← links)
- Stem cell transplantation and other novel techniques for promoting recovery from spinal cord injury (Q35781266) (← links)
- Canadian Association of Neuroscience review: axonal regeneration in the peripheral and central nervous systems--current issues and advances (Q35805856) (← links)
- Neurotensin-Conjugated Reduced Graphene Oxide with Multi-Stage Near-Infrared-Triggered Synergic Targeted Neuron Gene Transfection In Vitro and In Vivo for Neurodegenerative Disease Therapy (Q36180141) (← links)
- Molecular targets in spinal cord injury (Q36216362) (← links)
- Biomaterials and strategies for nerve regeneration (Q36534279) (← links)
- Olfactory ensheathing cell transplantation as a strategy for spinal cord repair--what can it achieve? (Q36753336) (← links)
- Physical activity-mediated functional recovery after spinal cord injury: potential roles of neural stem cells (Q36804505) (← links)
- Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine). (Q37079198) (← links)
- Neurotrophin selectivity in organizing topographic regeneration of nociceptive afferents (Q37387436) (← links)
- Use of autologous mesenchymal stem cells derived from bone marrow for the treatment of naturally injured spinal cord in dogs. (Q37641339) (← links)
- Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury (Q37710059) (← links)
- Gene transfer mediated by stem cell grafts to treat CNS injury (Q37948144) (← links)
- Combination therapies in the CNS: engineering the environment (Q37985448) (← links)
- Potential role of growth factors in the management of spinal cord injury (Q38075392) (← links)
- Olfactory ensheathing cells: part I—current concepts and experimental laboratory models (Q38090371) (← links)
- Gene therapy strategies for the treatment of spinal cord injury (Q38226668) (← links)
- Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation (Q38929153) (← links)
- A multipotent clonal human periodontal ligament cell line with neural crest cell phenotypes promotes neurocytic differentiation, migration, and survival (Q39507647) (← links)
- Combination of Multifaceted Strategies to Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Spinal Cord Repair (Q39577550) (← links)
- Neurotrophin-3 Gene-Modified Schwann Cells Promote TrkC Gene-Modified Mesenchymal Stem Cells to Differentiate into Neuron-Like Cells in Poly(Lactic-Acid-Co-Glycolic Acid) Multiple-Channel Conduit (Q39719343) (← links)
- Effect of adenovirus-mediated RNA interference of IL-1β expression on spinal cord injury in rats (Q40895091) (← links)
- Receptor tyrosine kinases: molecular switches regulating CNS axon regeneration (Q41819306) (← links)
- Controllable delivery of non-viral DNA from porous scaffolds (Q44254812) (← links)
- Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. (Q44487129) (← links)
- Nicotine upregulates nerve growth factor expression and prevents apoptosis of cultured spinal cord neurons (Q44624543) (← links)
- Stem cells and nervous tissue repair: from in vitro to in vivo (Q44709777) (← links)
- Prehospital management of spinal cord injuries (Q45245253) (← links)
- Preparation of the acellular scaffold of the spinal cord and the study of biocompatibility. (Q45399888) (← links)